Pathological MAPK activation–mediated lymphatic basement membrane disruption causes lymphangiectasia that is treatable with ravoxertinib
Harish P. Janardhan, Chinmay M. Trivedi(University of Massachusetts Chan Medical School)
Cited by 11
Related Papers
Plasticity of Hopx+ type I alveolar cells to regenerate type II cells in the lung
|Nature Communications|2015|309